Jianxin Huo

8PUBLICATIONS
29CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMedical molecular engineering of nucleic acids and proteinsVenereologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 03, 2026
Engineering a TACI×CD3 Bispecific Antibody to Redirect T Cells Against Multiple Myeloma.

|May 15, 2024
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.

Shi Yong Neo, Le Tong, Joni Chong

|May 12, 2023
The histone H2B ubiquitination regulator Wac is essential for plasma cell differentiation.

Yuxing Li, Gui-Xin Ruan, Wenjing Chen

|Nov 22, 2022
Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster.

Chin Shern Lau, John Thundyil, May Lin Helen Oh

|Jul 27, 2022
mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines.

Biyan Zhang, Jianxin Huo, Yuhan Huang

|Jul 01, 2022
Development of a T cell-redirecting bispecific antibody targeting B-cell maturation antigen for the suppression of multiple myeloma cell growth.

Jianxin Huo, Yuhan Huang, Ziying Zheng

Pageof 2

Frequent Collaborators

3 joint publications

Shengli Xu

2 joint publications

Tar Choon Aw

2 joint publications

Kong-Peng Lam

1 joint publications

Wei Zhang